CROSS JOHN HARRY III (Chief Financial Officer) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/5/2024ACC: 0001493152-24-048950
Officer· Chief Financial Officer
Since Apr 2020
-1.45K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.45K
Price / share
—
Trade value
—
% of position
47.8%
12/11/2023
3.04K→1.59K
Total
Net shares
−1.45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2023 | A · Award | −1.45K | — | — | 47.8% | 3.04K | 1.59K |
| Total | −1.45K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported